Calorimetric detection of influenza virus induced membrane fusion

Biochemistry ◽  
1995 ◽  
Vol 34 (17) ◽  
pp. 5705-5711 ◽  
Author(s):  
Simon Nebel ◽  
Ingrid Bartoldus ◽  
Toon Stegmann
1996 ◽  
Vol 431 (S6) ◽  
pp. R257-R258 ◽  
Author(s):  
Britta Schroth ◽  
Hans C. Philipp ◽  
Michael Veit ◽  
Michael F. G. Schmidt ◽  
Andreas Herrmann

1992 ◽  
Vol 267 (28) ◽  
pp. 20225-20232
Author(s):  
M Tsurudome ◽  
R Glück ◽  
R Graf ◽  
R Falchetto ◽  
U Schaller ◽  
...  

2012 ◽  
Vol 102 (3) ◽  
pp. 604a
Author(s):  
Caroline Mair ◽  
P. Sivaramakrishna Rachakonda ◽  
Thomas Korte ◽  
Andreas Herrmann

1989 ◽  
Vol 31 (4) ◽  
pp. 460
Author(s):  
KoertN.J. Burger ◽  
Gerhard Knoll ◽  
Gerrit van Meer ◽  
ArieJ. Verkleij

1994 ◽  
Vol 75 (2) ◽  
pp. 395-399 ◽  
Author(s):  
C. C. Pak ◽  
M. Krumbiegel ◽  
R. Blumenthal

2021 ◽  
Vol 14 (6) ◽  
pp. 587
Author(s):  
Zhaoyu Chen ◽  
Qinghua Cui ◽  
Michael Caffrey ◽  
Lijun Rong ◽  
Ruikun Du

Hemagglutinin (HA) plays a critical role during influenza virus receptor binding and subsequent membrane fusion process, thus HA has become a promising drug target. For the past several decades, we and other researchers have discovered a series of HA inhibitors mainly targeting its fusion machinery. In this review, we summarize the advances in HA-targeted development of small molecule inhibitors. Moreover, we discuss the structural basis and mode of action of these inhibitors, and speculate upon future directions toward more potent inhibitors of membrane fusion and potential anti-influenza drugs.


Sign in / Sign up

Export Citation Format

Share Document